Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy

This metadata record provides details of the data supporting the claims of the related manuscript: "Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy", Mallard de La Varende et al., 2026 - Human metabolomic data are available in : CANCER-CELL-D-25-01204R2_Human_Bile_acids_data.xlsx - Mouse metabolomic data are available in : CANCER-CELL-D-25-01204R2_Mouse_Bile_acids_data.xlsx - Human metagenomic data for s-score and TOPOSCORE calculations are available in : CANCER-CELL-D-25-01204R2_Human_Toposcore_data.xlsx